Medicine

AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis

May 8, 2024 - By 

Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs.

Related Posts

FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk

February 19, 2025

Navigating Distrust: Pharma in the Age of Social Media

February 19, 2025

Pharmaceutical Executive: February 2025 Issue (PDF)

February 18, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *